Suffruticosol B from Paeonia lactiflora Ameliorates Alzheimer’s Disease Pathology by Inhibiting MAO-B Activity

Written by

·

Jae-Jun HeoYoung-Eun HanMin Soo KimEunji CheongChun Whan ChoiSoo-Jin Oh (Yonsei University)

Phytotherapy Research (2025)

Suffruticosol B: specific chemical compounds natural products found in the medicinal plant Paeonia suffruticosa (tree peony), and known for potential health benefits.

MAO-B Activity: function of Monoamine Oxidase B, an enzyme that breaks down neurotransmitters like dopamine and plays a role in oxidative stress, influencing neurological health, aging, and conditions like Parkinson’s and Alzheimer’s diseases

Abstract:

  • The study tested whether Suf-B alleviates Alzheimer’s disease (AD) pathology by inhibiting MAO-B in reactive astrocytes.
  • Suf-B’s effects – assessed through enzyme assays, behavioral tests, immunohistochemistry, and electrophysiology in an AD mouse model.
  • Suf-B significantly inhibited MAO-B activity without cytotoxicity and reduced astrocyte reactivity and abnormal GABA production → restored cognitive function in AD mice, suggesting therapeutic potential.

Findings:

  • Suf-B effectively inhibits MAO-B, a target linked to astrocyte-mediated GABA overproduction in AD.
  • Suf-B reduced reactive astrogliosis and abnormal tonic GABA release that ends neuronal activity.
  • Behavioral tests (e.g., maze and object recognition) showed improved cognitive performance after Suf-B treatment.
  • Electrophysiology confirmed that Suf-B normalized neuronal inhibition in the hippocampus.

Conclusion:

  • Suf-B → neuroprotective efficacy in an AD mouse model by targeting MAO-B.
  • Alleviates AD pathology by reducing astrocyte reactivity and excessive GABA-mediated neuronal inhibition.
  • Cognitive function was restored in experimented mice → potential for AD therapy.
  • Results support further development of Suf-B as a candidate treatment for AD and other diseases involving reactive astrogliosis.

댓글 남기기